TY - JOUR
T1 - Practice of ultrasound-guided arthrocentesis and joint injection, including training and implementation, in Europe: Results of a survey of experts and scientific societies
AU - Mandl, Peter
AU - Naredo, Esperanza
AU - Conaghan, Philip G.
AU - D'Agostino, Maria-Antonietta
AU - D'Agostino, Maria Antonietta
AU - Wakefield, Richard J.
AU - Bachta, Artur
AU - Backhaus, Marina
AU - Hammer, Hilde B.
AU - Bruyn, George A. W.
AU - Damjanov, Nemanja
AU - Filippucci, Emilio
AU - Grassi, Walter
AU - Iagnocco, Annamaria
AU - Jousse-Joulin, Sandrine
AU - Kane, David
AU - Koski, Juhani M.
AU - Möller, Ingrid
AU - De Miguel, Eugenio
AU - Schmidt, Wolfgang A.
AU - Swen, Wijnand A. A.
AU - Szkudlarek, Marcin
AU - Terslev, Lene
AU - Ziswiler, Hans-Rudolf
AU - Østergaard, Mikkel
AU - Balint, Peter V.
PY - 2012
Y1 - 2012
N2 - Objectives: To document the practice and training opportunities of US-guided arthrocentesis and joint injection (UGAJ) among rheumatologists in the member countries of the European League Against Rheumatism (EULAR). Methods: An English-language questionnaire, containing questions on demographics, clinical and practical aspects of UGAJ, training options in UGAJ for rheumatologists, UGAJ education in the rheumatology training curriculum and other structured education programmes in UGAJ was sent to three different groups: (i) all national rheumatology societies of EULAR; (ii) all national societies of the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB); and (iii) 22 senior rheumatologists involved in EULAR musculoskeletal US training from 14 European countries, who were also asked to circulate the questionnaire among relevant colleagues. Results: Thirty-three (75%) of 44 countries responded to the questionnaire (61.3% of national rheumatology societies, 25% of the national US societies and 100% of expert ultrasonographers). In the majority of countries (85%) <10% of rheumatologists routinely perform UGAJ in clinical practice, while the remaining countries (15%) reported a rate of 10-50%. The percentage of rheumatologists receiving training in UGAJ was <10% in the majority (72.7%) of countries. Conclusion: The study highlights the relatively low prevalence of UGAJ as compared with the high (>80%) rate of rheumatologists performing conventional joint injection in most of the surveyed countries. The reported variations in practice and the lack of available structured training programmes for trainees in most countries indicates the need for standardization in areas including training guidelines. © The Author 2011. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved.
AB - Objectives: To document the practice and training opportunities of US-guided arthrocentesis and joint injection (UGAJ) among rheumatologists in the member countries of the European League Against Rheumatism (EULAR). Methods: An English-language questionnaire, containing questions on demographics, clinical and practical aspects of UGAJ, training options in UGAJ for rheumatologists, UGAJ education in the rheumatology training curriculum and other structured education programmes in UGAJ was sent to three different groups: (i) all national rheumatology societies of EULAR; (ii) all national societies of the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB); and (iii) 22 senior rheumatologists involved in EULAR musculoskeletal US training from 14 European countries, who were also asked to circulate the questionnaire among relevant colleagues. Results: Thirty-three (75%) of 44 countries responded to the questionnaire (61.3% of national rheumatology societies, 25% of the national US societies and 100% of expert ultrasonographers). In the majority of countries (85%) <10% of rheumatologists routinely perform UGAJ in clinical practice, while the remaining countries (15%) reported a rate of 10-50%. The percentage of rheumatologists receiving training in UGAJ was <10% in the majority (72.7%) of countries. Conclusion: The study highlights the relatively low prevalence of UGAJ as compared with the high (>80%) rate of rheumatologists performing conventional joint injection in most of the surveyed countries. The reported variations in practice and the lack of available structured training programmes for trainees in most countries indicates the need for standardization in areas including training guidelines. © The Author 2011. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved.
KW - Education
KW - Education, Medical, Continuing
KW - Europe
KW - Health Care Surveys
KW - Humans
KW - Injections, Intra-Articular
KW - Musculoskeletal Diseases
KW - Musculoskeletal ultrasound
KW - Paracentesis
KW - Practice Patterns, Physicians'
KW - Professional Practice
KW - Radiology
KW - Rheumatology
KW - Societies, Medical
KW - Training
KW - Ultrasonography, Interventional
KW - Ultrasound-guided arthrocentesis
KW - Ultrasound-guided joint injection
KW - Education
KW - Education, Medical, Continuing
KW - Europe
KW - Health Care Surveys
KW - Humans
KW - Injections, Intra-Articular
KW - Musculoskeletal Diseases
KW - Musculoskeletal ultrasound
KW - Paracentesis
KW - Practice Patterns, Physicians'
KW - Professional Practice
KW - Radiology
KW - Rheumatology
KW - Societies, Medical
KW - Training
KW - Ultrasonography, Interventional
KW - Ultrasound-guided arthrocentesis
KW - Ultrasound-guided joint injection
UR - http://hdl.handle.net/10807/169310
U2 - 10.1093/rheumatology/ker331
DO - 10.1093/rheumatology/ker331
M3 - Article
SN - 1462-0324
VL - 51
SP - 184
EP - 190
JO - Rheumatology
JF - Rheumatology
ER -